Bionomics American Depository Shares Stock News

Healthcare > Biotechnology

Buy BNOX

*Your capital is at risk

$0.253

+0 (+0%)

At Close: Mar 26, 2025

Bionomics Completes Last Patient Last Visit in the Phase 2b ATTUNE Study for Post-Traumatic Stress Disorder (PTSD) and Confirms Expected 2023 Milestones with its Lead Asset BNC210

06:00am, Wednesday, 23'rd Aug 2023

ADELAIDE, Australia, and CAMBRIDGE, Mass., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biotechnology company developing nove

Quarterly Activities and Cashflow Report

06:00am, Monday, 31'st Jul 2023

ADELAIDE, Australia, and CAMBRIDGE, Mass., July 31, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO), (Bionomics or the Company) a clinical-stage biopharmaceutical company develop

Bionomics Announces Intention to Delist from the Australian Securities Exchange (ASX)

06:00am, Tuesday, 25'th Jul 2023

ADELAIDE, Australia and CAMBRIDGE, Mass., July 25, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO, NASDAQ:BNOX) (Bionomics or the Company) a clinical-stage biotechnology company developing novel,

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by